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Abstract — Aims: The aim of this article is to review the forensic literature covering the postmortem investigations that are associated with
alcoholic ketoacidosis fatalities and report the results of our own analyses.Methods: Eight cases of suspected alcoholic ketoacidosis that had
undergone medico-legal investigations in our facility from 2011 to 2013 were retrospectively selected. A series of laboratory parameters were
measured in whole femoral blood, postmortem serum from femoral blood, urine and vitreous humor in order to obtain a more general over-
view on the biochemical and metabolic changes that occur during alcoholic ketoacidosis. Most of the tested parameters were chosen among
those that had been described in clinical and forensic literature associated with alcoholic ketoacidosis and its complications. Results: Ketone
bodies and carbohydrate-deficient transferrin levels were increased in all cases. Biochemical markers of generalized inflammation, volume de-
pletion and undernourishment showed higher levels. Adaptive endocrine reactions involving insulin, glucagon, cortisol and triiodothyronine
were also observed. Conclusions:Metabolic and biochemical disturbances characterizing alcoholic ketoacidosis can be reliably identified in
the postmortem setting. The correlation of medical history, autopsy findings and biochemical results proves therefore decisive in identifying
pre-existing disorders, excluding alternative causes of death and diagnosing alcoholic ketoacidosis as the cause of death.
INTRODUCTION
Alcoholic ketoacidosis: definition and clinical features
The entity of alcoholic ketoacidosis, sometimes called alco-
holic acidosis in the literature, was first described by Dillon
et al. in 1940. In this report, the authors described a series of
nine patients who had episodes of severe ketoacidosis in the
absence of diabetes mellitus. All of these patients also had evi-
dence of prolonged, excessive alcohol consumption (Dillon
et al., 1940; Höjer, 1996; Tanaka et al., 2004; McGuire et al.,
2006).
The suggestion by Dillon et al. that ketoacidosis might occur
in non-diabetic, chronic alcohol abusers was not supported by
further observations until 1970 when Jenkins et al. (1971)
described a series of three non-diabetic individuals with a
history of chronic, heavy alcohol misuse and recurrent episodes
of ketoacidosis. Similar case studies were subsequently
reported by Levy et al. (1973), Cooperman et al. (1974), Fulop
and Hoberman (1975), Platia and Hsu (1979), Soffer and
Hamburger (1982), Halperin et al. (1983), Fulop et al. (1986)
and Wrenn et al. (1991), with remarkably consistent features:
all patients described in these reports had a history of chronic
alcohol abuse and recent, particularly excessive intake, abruptly
terminated some days prior due to abdominal pain and repeated
vomiting.
Alcoholic ketoacidosis only affects patients who have a
history of chronic alcohol abuse (Höjer, 1996; Tanaka et al.,
2004). The clinical features are very similar to those of diabetic
ketoacidosis (Smith et al., 1999). Diabetics who abuse alcohol
can also develop alcoholic ketoacidosis, though there is no
documented connection between diabetic and alcoholic ketoa-
cidosis. In exceptional cases, the two conditions can be co-
existent (Höjer, 1996; Tanaka et al., 2004). Some of the patients
who develop alcoholic ketoacidosis appear to be prone to
repeated episodes (Höjer, 1996). In typical cases, the onset of
the syndrome is preceded by prolonged, massive alcohol intake
followed by abrupt cessation of ethanol consumption a few
days earlier due to nausea, severe vomiting and abdominal
pain, often induced by gastritis and pancreatitis (Halperin et al.,
1983; Duffens and Marx, 1987; Wrenn et al., 1991; Smith
et al., 1999; Tanaka et al., 2004; McGuire et al., 2006). This
common presenting feature of vomiting is probably the result
of ethanol-induced oesophagitis or gastritis and may inhibit all
or most food and fluid intake, in some cases for several days
(Halperin et al., 1983; Duffens and Marx, 1987; Smith et al.,
1999).
On physical examination, beyond the typical signs of
chronic alcohol abuse, these patients may present hyperventi-
lation, tachycardia, hypotension and signs of dehydration due
to the decreased fluid intake and severe vomiting described
above. Though these subjects are in overall, poor conditions,
the syndrome does not include any actual loss of conscious-
ness. In contrast to patients with diabetic ketoacidosis, subjects
with alcoholic ketoacidosis are usually alert and lucid despite
the severity of the acidosis and marked ketonemia (Höjer,
1996;McGuire et al., 2006; Rehman, 2012).
When altered mental status and loss of consciousness do
occur, they are typically attributable to other underlying, compli-
cating factors such as hypoglycemia or severe infection
(McGuire et al., 2006). Abdominal pain may be seen as part of
the syndrome and may be caused by a myriad of entities, includ-
ing acute alcoholic hepatitis, pancreatitis and alcoholic gastritis
(Duffens and Marx, 1987; Höjer, 1996; Smith et al., 1999;
McGuire et al., 2006;Rehman, 2012).
It can be difficult at presentation to distinguish between
ethanol, methanol and ethylene glycol toxicity in an alcoholic
patient with an increased anion gap, metabolic acidosis and a
higher serum osmolal gap. Additional diagnostic possibilities,
which may be concurrent abnormalities, include lactic acidosis
and diabetic ketoacidosis (Höjer, 1996; Tanaka et al., 2004;
McGuire et al., 2006). Main laboratory findings reflect the se-
verity of the ketoacidosis as well as that of fluid and electrolyte
disturbances secondary to vomiting and dehydration (Fulop,
1993). The mechanisms giving rise to alcoholic ketoacidosis are
numerous. The syndrome arises through the various metabolic
effects of alcohol in the fasted, volume-depleted, alcoholic who
has abruptly stopped his alcohol intake. The ketoacids respon-
sible for alcoholic ketoacidosis (beta-hydroxybutyrate and acet-
oacetate) are in part formed because of the metabolism of
ethanol in the liver. Ethanol is oxidized to acetaldehyde in the
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liver cytoplasm by alcohol dehydrogenase. In the liver mito-
chondria, acetaldehyde is oxidized to acetic acid by aldehyde
dehydrogenase. These oxidative processes lead to an accumula-
tion of reduced form of nicotinamide-adenine dinucleotide
(NADH), and resultant increased NADH/nicotinamide-adenine
dinucleotide (NAD) ratio. Acetic acid (acetate) is converted to
acetyl coenzyme A, which can enter the citric acid cycle, form
ketone bodies or be converted to fat. Acetoacetate and beta-
hydroxybutyrate formation in alcoholic ketoacidosis has several
causes. An increase in production follows from the oxidation of
ethanol. It also occurs in response to starvation and the extracel-
lular fluid volume depletion arising from vomiting, decreased
fluid intake and inhibition of antidiuretic hormone secretion by
alcohol. Moreover, dehydration and volume contraction impair
the excretion of ketones by the kidneys, leading to further eleva-
tion in ketone levels. Numerous hormonal changes in alcoholic
ketoacidosis mediate free fatty acid release through lipolysis,
which provides substrate for subsequent ketone body formation
(Duffens and Marx, 1987).
Variably severe metabolic acidosis with an increased anion
gap is generally present. The main source of the large anion gap
is the accumulation of acetoacetate and beta-hydroxybutyrate in
blood that can be detected, along with acetone, in both blood
and urine. Various acid-base disturbances have also been
reported. In some series, most patients presented with metabolic
acidosis with compensatory hyperventilation. Other patients
may have combinations of metabolic acidosis, primary respira-
tory alkalosis due to abdominal pain and metabolic alkalosis
secondary to vomiting (Fulop, 1993).
Decreased serum chloride and bicarbonate levels reflect the
acid-base disturbances as well as the presence and severity of
vomiting. Glucose concentrations in the blood and urine are
usually normal, though both hypoglycemia and mild hyper-
glycemia may occur. Since abdominal pain and vomiting
prevent the patient from drinking alcohol, serum ethanol is
often low or undetectable on presentation (Fulop, 1979, 1989;
Soffer and Hamburger, 1982; Palmer, 1983; Adams, 1990;
Caspar et al., 1993; Höjer, 1996; Lu et al., 1997; Umpierrez
et al., 2000; Sibaï and Eggiman, 2005;McGuire et al., 2006).
Liver tests may be pathological as a result of chronic alco-
holism (Höjer, 1996). Serum lactate concentrations have been
reported to be moderately increased in most cases and severely
elevated only in patients who have concomitant, underlying
complications responsible for increased lactate production or
impaired clearance, such as pneumonia with hypoxia, sepsis
or severe hepatic disorders. Some authors have reported
patients with alcoholic ketoacidosis having higher blood
lactate concentrations and a higher lactate to pyruvate ratio than
those seen in patients with diabetic ketoacidosis (Fulop, 1979,
1989; Soffer and Hamburger, 1982; Palmer, 1983;Adams, 1990;
Caspar et al., 1993; Höjer, 1996; Lu et al., 1997; Umpierrez
et al., 2000; Sibaï and Eggiman, 2005;McGuire et al., 2006).
Many patients with alcoholic ketoacidosis have been found to
have extremely elevated concentrations of plasma free fatty acids,
with mean levels much higher than those observed in patients
with diabetic ketoacidosis (Levy et al., 1973; Cooperman et al.,
1974;McGuire et al., 2006). Subjects with alcoholic ketoacidosis
also have markedly raised cortisol, glucagon, catecholamine and
growth hormone levels as well as relatively low or normal
plasma insulin levels, as is common in starvation, whose pres-
ence is also supported by the finding of subnormal plasma
triiodothyronine levels (Fulop et al., 1986;McGuire et al., 2006).
Elevated serum amylase has been observed in about 50% of
these patients. A higher serum osmolal gap has been described
in some cases and attributed to the accumulation of glycerol,
acetone and acetone metabolites such as acetol and
1,2-propanediol. Serum uric acid, sodium, potassium, calcium,
magnesium and phosphate level disorders have also been
described, though not systematically (Fulop, 1979, 1989;
Soffer and Hamburger, 1982; Palmer, 1983; Adams, 1990;
Caspar et al., 1993; Höjer, 1996; Lu et al., 1997; Umpierrez
et al., 2000; Sibaï and Eggiman, 2005;McGuire et al., 2006).
When treated, alcoholic ketoacidosis may be rapidly and
completely resolved with no apparent sequelae. However, nu-
merous forensic studies have shown that untreated cases in
individuals with severe alcoholism may be associated with
sudden death (McGuire et al., 2006).
Alcoholic ketoacidosis in the forensic setting:
acetone and beta-hydroxybutyrate determination
Though sudden unexplained deaths in chronic alcohol abusers
with hepatic steatosis, also reported as fatty liver-related
sudden deaths, had been commonly reported by pathologists
worldwide over the years, the pathogenesis remained unclear.
Low or undetectable blood ethanol levels were frequently mea-
sured in these cases, raising the question of whether the fatal
outcome was related to the metabolic consequences of ethanol
withdrawal. The difficulties in establishing the pathogenesis of
death with precision in such situations were mainly attributed
to two factors. Firstly, most of these cases were not witnessed,
contributing to the paucity of clinical information. Secondly,
potentially lethal metabolic and biochemical disturbances
existing at the time of death could not be reliably identified and
diagnosed by postmortem investigations (Kuller et al., 1974;
Randall, 1980a,b; Copeland, 1985; Clark, 1988; Petersson,
1988; Hansen and Simonsen, 1991; Yuzuriha et al., 1993,
1997).
The first report in the forensic field suggesting that ketoaci-
dosis could be partially responsible for unexplained deaths in
alcoholics dates back to 1993 and concerns a study performed
by L.N. Denmark on 49 autopsy cases that included chronic
alcohol abuse-related deaths. Some of the latter were found to
have increased vitreous and urine beta-hydroxybutyrate con-
centrations as well as low or undetectable blood ethanol.
Based on these results and similar features in the clinical field,
Denmark postulated that ketoacidosis may play a role in the
multi-factorial, metabolic catastrophe leading to death in situa-
tions of alcohol withdrawal (Denmark, 1993).
Succeeding Denmark, numerous researchers investigated
blood ethanol levels as well as acetone and beta-hydroxybutyrate
in blood and alternative biological fluids in suspected alcoholic
ketoacidosis deaths. Different reference values have been pro-
posed for acetone and beta-hydroxybutyrate in blood, vitreous,
pericardial and cerebrospinal fluids to ascribe the cause of death
to alcoholic ketoacidosis in the presence of other consistent data
and exclusion of alternative causes of death. Vitreous and peri-
cardial fluid have been shown to be reliable alternative to blood
in case of blood unavailability and beta-hydroxybutyrate a more
suitable indicator of alcoholic ketoacidosis than acetone. Blood
beta-hydroxybutyrate reference values can be used for vitreous
and pericardial fluid for diagnostic purposes. Some researchers
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also emphasized that blood ethanol is not systematically low or
absent in alcoholic ketoacidosis deaths and that low or absent
acetone levels do not preclude the presence of pathologically sig-
nificant beta-hydroxybutyrate concentrations (Thomsen et al.,
1993, 1995, 1997; Thomsen and Frohlich, 1995; Thomsen,
1996; Brinkmann et al., 1998; Pounder et al., 1998; Kadiš et al.,
1999; Iten and Meier, 2000; Kanetake et al., 2005; Buszewicz
et al., 2007; Felby et al., 2008; Teresin´ski et al., 2009; Elliott
et al., 2010; Molina, 2010; Heninger, 2012; Hockenhull et al.,
2012; Palmiere et al., 2012, 2013a) (Table 1).
Other biochemical and histological markers for alcoholic
ketoacidosis
Isopropyl alcohol may be considered a marker of ketoacidosis
and a product of acetone metabolism in clinical conditions
presenting ketonemia. The compound can be detected in
several situations of forensic interest, beyond direct exposure
to isopropyl alcohol itself, which are characterized by
increased acetone levels and an elevated NADH/NAD+ ratio,
such as diabetic and alcoholic ketoacidosis as well as hypo-
thermia fatalities and starvation (Palmiere et al., 2012).
The results of isopropyl alcohol determination in cases of
sudden death in chronic alcoholics were reported among
others by Teresin´ski et al., with measured concentrations in
femoral blood ranging from 1 to 38 µmol/l (0.06–2.29 mg/l),
and Palmiere et al., with measured concentrations in femoral
blood ranging from 18 to 116 µmol/l (1.1–7.0 mg/l) (Teresin´ski
et al., 2009; Palmiere et al., 2012).
Significantly higher blood and vitreous isopropyl alcohol con-
centrations in chronic ethanol users were found by Molina, with
measured blood values ranging from 0 to 71 mg/dl (median
value 15 mg/dl) and vitreous values ranging from 0 to 81 mg/dl
(median value 12 mg/dl), Petersen et al., who identified an
average concentration of isopropyl alcohol of 18.5 ± 22.1 mg/dl
in 79 alcoholic ketoacidosis cases, and Dwyer and Tamama,
who found a blood concentration of isopropyl alcohol of 6 mg/
dl in a case of severe alcoholic ketoacidosis (Molina, 2010;
Petersen et al., 2012;Dwyer and Tamama, 2013).
C-reactive protein (CRP) levels in alcoholic ketoacidosis
have been investigated by Lindroos-Jokinen et al., who
observed that CRP can successfully be measured in blood
samples collected during autopsy up to 18 days after death and
that ketoacidosis itself, either diabetic or alcoholic, is associated
with increased CRP values without any other obvious, under-
lying causes, such as infection or trauma, which typically lead
to higher CRP concentrations. Additionally, the authors high-
lighted that some degree of liver disease (mainly hepatic stea-
tosis or incipient liver cirrhosis), commonly present in chronic
alcoholics, does not seem to elevate CRP levels substantially
(Lindroos-Jokinen et al., 2012).
Recent reports by Parai et al. and Zhou et al. focused on
histological findings consistent with the existence of ketoacido-
sis (either diabetic or alcoholic) at the time of death, namely the
sub-nuclear vacuolation of the proximal tubules in the kidneys,
mostly associated with diabetic ketoacidosis, and formalin
pigment deposition in the vacuolated epithelial cells of the
proximal tubules in the kidneys. According to the authors, the
latter finding can prove extremely useful in cases of ketoacido-
sis and severe renal tubular epithelium degradation due to post-
mortem autolysis and decompositional changes (Parai et al.,
2012; Zhou et al., 2013).
MATERIAL ANDMETHODS
Study design
With the hope of providing a more complete approach pertain-
ing to the postmortem biochemical analyses that can be per-
formed in cases of suspected alcoholic ketoacidosis, we
selected eight cases that had undergone medico-legal investi-
gations in our facility and for which the cause of death had
been determined to be alcoholic ketoacidosis based on data
obtained from the medical and social histories of the deceased
as well as scene investigations and postmortem findings.
Alternative causes of death were excluded based on all post-
mortem investigation results. Circumstantial elements, autopsy
and histology did not suggest exposure to cold or hypothermia
as a contributing factor to death in any of these cases.
All cases were selected among the medico-legal autopsies
performed in our center from 2011 to 2013. The main criterion
for selection was the availability of femoral blood, postmortem
serum from femoral blood, cardiac blood, vitreous humor,
urine and cerebrospinal fluid during autopsy. The cases
included eight males between 49 and 69 years of age, with a
mean age of 58. According to the medical records, all indivi-
duals were non-diabetic. Additionally, glycated hemoglobin
levels were measured and found to be normal in all cases.
All autopsies were performed within 24 h after body dis-
covery. The interval between the supposed times of death and
autopsies did not exceed 72 h.
A series of laboratory parameters were measured in order to
obtain a more general overview on the biochemical and meta-
bolic changes occurring during alcoholic ketoacidosis.
Most of these parameters were chosen among those that had
been described in clinical and forensic literature associated with
alcoholic ketoacidosis and its complications. These may include
starvation, extracellular fluid volume depletion, impaired renal
function, various hormonal changes and bacterial infections. In
order to investigate chronic alcohol abuse, concomitant diabetes
mellitus as well as cardiac ischemia and cardiac failure, other
biochemical markers among those that are currently measured
in the postmortem setting were also determined (Coe, 1991;
Palmiere and Mangin, 2012a,b).
The tested parameters include:
– glucose, sodium, chloride and lactate in vitreous,
– glucose in urine,
– glycated hemoglobin in femoral whole blood,
– beta-hydroxybutyrate in femoral whole blood and
vitreous,
– ethanol in blood,
– carbohydrate-deficient transferrin (CDT) in postmortem
serum from femoral blood,
– cortisol in postmortem serum from femoral blood,
– free cortisol in urine,
– free fatty acids in postmortem serum from femoral
blood,
– procalcitonin (PCT), CRP, lipopolysaccharide-binding
protein (LBP), interleukin-6 (IL-6) and interleukin-10
(IL-10) in postmortem serum from femoral blood,
– pancreatic amylase (P-amylase) and gamma glutamyl
transferase (gamma-GT) in postmortem serum from
femoral blood,
– insulin, C-peptide and glucagone in postmortem serum
from femoral blood,
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Table 1. Beta-hydroxybutyrate and acetone determination results in vitreous, blood and urine as well as the proposed reference values for the diagnosis
of alcoholic ketoacidosis
Author Vitreous BHB Blood BHB Urine BHB
Acetone
(vitreous-blood-urine)
Proposed reference
value(s)
Denmark (1993) 1825–2585 µmol/l
(19–26.9 mg/dl)
2565–47,353 µmol/l
(26.7–493 mg/dl)
Thomsen et al. (1993) Blood ketone sum
531 µmol/l
Pounder et al. (1998) Blood ketone sum
10,000 µmol/l
Vitreous ketone sum
5000 µmol/l
Brinkmann et al. (1998) Blood acetone
1655–6896 µmol/l
(9.6–40 mg/dl)
Blood acetone
9 mg/dl
(1548 µmol/l)
Kadiš et al. (1999) Blood-urine-vitreous
BHB 3000 µmol/l
(31.2 mg/dl)
Iten and Meier (2000) 1260–47,200 µmol/l
(13.1–491.4 mg/dl)
Blood BHB
<500 µmol/l
(5.2 mg/dl): normal
500–2500 µmol/l
(5.2–26 mg/dl):
increased
>2500 µmol/l
(26 mg/dl): pathologic
Kanetake et al. (2005) Blood BHB
1000 µmol/l
(10.4 mg/dl)
Teresin´ski et al. (2009) Blood acetone
487–5150 µmol/l
(2.8–29.9 mg/dl)
Hockenhull et al. (2012) 3343–17,097 µmol/l
(34.7–178 mg/dl)
Palmiere et al. (2012) 1065–1130 µmol/l
(11.1–11.8 mg/dl)
1650–2400 µmol/l
(17.2–25 mg/dl)
1100–3180 µmol/l
(11.5–33.1 mg/dl)
Blood acetone
431–1172 µmol/l
(2.5–6.8 mg/dl)
Urine acetone
724–3259 µmol/l
(4.2–18.9 mg/dl)
Vitreous acetone
328–1224 µmol/l
(1.9–7.1 mg/dl)
Molina (2010) Blood acetone
0–195 mg/dl
Vitreous acetone
0–231 mg/dl
Elliott et al. (2010) Blood BHB
<480 µmol/l
(5 mg/dl): normal
480–2400 µmol/l
(5–25 mg/dl): increased
>2400 µmol/l
(25 mg/dl): pathologic
Palmiere et al. (2013a) Blood-vitreous-pericardial
fluid
2500 µmol/l
(26 mg/dl)
Cerebrospinal fluid
2000 µmol/l
(20.8 mg/dl)
Heninger (2012) Vitreous BHB
1200–2000 µmol/l
(12.5–20.8 mg/dl):
moderately elevated
2000–6000 µmol/l
(20.8–62.6 mg/dl):
significantly elevated
>6000 µmol/l
(62.6 mg/dl):
life-threatening
BHB, beta-hydroxybutyrate
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– urea nitrogen, creatinine and uric acid in postmortem
serum from femoral blood,
– free triiodothyronine (fT3) in postmortem serum from
femoral blood,
– troponin I (cTnI), N-terminal pro-brain natriuretic
peptide (NT-proBNP) in postmortem serum from
femoral blood,
– pre-albumin and albumin in postmortem serum from
femoral blood.
All cases selected for this study underwent complete autop-
sies preceded by unenhanced CT-scans. Histology, toxicology,
neuropathology, microbiology and biochemical investigations
were performed in all cases. Specimens for microbiology were
collected from at least two different sampling sites and always
included cardiac blood and cerebrospinal fluid. Medical records
and social histories of the deceased as well as police reports
were reviewed consistently before conclusions were made.
Since all cases selected for this study originated from foren-
sic practice with deaths occurring outside the hospital, data on
antemortem biochemical results were not available.
Sample collection
Undiluted vitreous samples (between 1 and 3 ml) were obtained
by aspiration using a sterile needle and syringe as soon as pos-
sible after arrival of the bodies at the morgue. Right and left vit-
reous samples were collected through a scleral puncture at the
lateral canthus, aspirated from the center of each eye, pooled in
the same syringe and mixed together. After collection, the vitre-
ous samples were immediately centrifuged at 3000 g for 15
min. The separated supernatant was collected and stored in
preservative-free tubes. No specimens were excluded due to in-
sufficient sample volume. All samples were transferred to the
laboratories immediately post collection. When analyzes were
delayed, samples were stored at −20°C.
Urine samples were collected by bladder aspiration during
the autopsy, stored in preservative-free tubes and frozen at
−20°C until analysis.
Femoral blood samples were collected by aspiration with a
sterile needle and a syringe from the femoral vein(s) during
autopsy. Blood samples were drawn after clamping the vein(s) at
the proximal end and lifting the lower limb(s) for several
minutes. Femoral blood was stored in tubes containing sodium
fluoride (for ethanol, acetone, acetoacetate, beta-hydroxybutyrate
and isopropyl alcohol determination) and tubes containing
ethylenediaminetetraacetic acid (for glycated hemoglobin deter-
mination). All samples were transferred to the laboratories imme-
diately post collection. When analyses were delayed, samples
were stored at −20°C. Blood samples were also collected in
preservative-free tubes and centrifuged immediately after collec-
tion at 3000 g for 15 min. After centrifugation, the separated
supernatant (postmortem serum) was collected and stored in
preservative-free tubes.
The external side of the right atrium of the heart was steri-
lized by searing with a heated scalpel blade and cardiac blood
was aspirated using a syringe. Once collected, cardiac blood
was stored in blood-culture bottles (aerobic and anaerobic)
and immediately incubated at 37°C.
Cerebrospinal fluid was collected by aspiration using a
sterile needle and a syringe by suboccipital puncture as soon
as possible after arrival of the bodies at the morgue or from the
lateral ventricles and cisternal space during autopsy. Post col-
lection, cerebrospinal fluid was stored in blood-culture bottles
(aerobic and anaerobic) and immediately incubated at 37°C.
Analytical techniques
Glucose was analyzed in vitreous and urine stored in
preservative-free tubes on the Roche Modular P clinical chem-
istry system (glucose hexokinase method). Lactate was deter-
mined in vitreous stored in preservative-free tubes on the
Roche Modular P clinical chemistry system (lactate oxydase
method).
Sodium and chloride were analyzed in vitreous stored in
preservative-free tubes on the Roche Modular P clinical chem-
istry system. Concentrations were determined by an indirect
potentiometry assay (ion selective-electrode using indirect po-
tentiometry).
Ethanol, acetone and isopropyl alcohol were determined in
whole femoral blood stored in tubes containing sodium fluor-
ide by the use of headspace gas chromatography with flame
ionization detection on an Agilent 1888 headspace and a 6850
GC (Palo Alto, CA, USA). The samples were incubated for
20 min at 80°C and then expanded to the GC column.
The CDT was analyzed in postmortem serum from femoral
blood using capillary zone electrophoresis equipped with a
UV detector set at 210 nm and using a commercial assay kit
(CEofix™ CDT, Analis).
Glycated hemoglobin was determined in femoral whole
femoral blood samples stored in tubes containing ethylenediami-
netetraacetic acid by ion-exchange high-performance liquid chro-
matography (Bio-Rad D-10 Dual Program, Hercules, CA, USA).
Beta-hydroxybutyrate and acetoacetate concentrations were
determined in femoral whole blood anticoagulated with
sodium fluoride and vitreous stored in preservative-free tubes
on a Cobas Mira Plus (Roche Diagnostics, Switzerland) by an
enzymatic photometric method adapted in house from the
technique described by Ruell and Gass (1991). Refrigerated or
frozen samples thawed overnight at 4°C were deproteinized
with perchloric acid and supernatant was used for analysis.
NT-proBNP and PCT were measured in postmortem serum
from femoral blood with the commercially available immu-
noassays on the Roche Modular E170 system (Roche
Diagnostics GmbH, Mannheim, Germany).
Creatinine (Jaffé method, rate-blanked and compensated),
urea nitrogen (kinetic enzymatic UV assay for urea/urea nitro-
gen), uric acid (enzymatic uricase colorimetric AU Plus) and
CRP (immunoturbidimetric Tina-quant CRP) were determined
with the Roche standard methods on the Roche Modular P
system (Roche Diagnostics GmbH, Mannheim, Germany).
Troponin I was analyzed in postmortem serum from
femoral blood with the Access® AccuTnITM assay on Access
II (Beckman Coulter, Fullerton, CA, USA).
Free fatty acids were quantified in postmortem serum from
femoral blood by the enzymatic colorimetric method
‘NEFA-HR(2)’ (Wako Diagnostics, USA) adapted on a Cobas
MIRA Plus (Roche Diagnostics, Switzerland).
Albumin concentration was determined by the bromocresol
green method. Prealbumin was measured by immunoturbidi-
metric method (Spectra East, Rockleigh, NJ, USA).
Postmortem serum cortisol was determined by fluorescent
polarization immunoassay available on the Axsym analyzer
(Abbott laboratories, Abbott Park, IL, USA).
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Determination of insulin, C-peptide and glucagon in post-
mortem serum from femoral blood was performed by radio-
immunoassay (RIA) method.
Pancreatic amylase activity in postmortem serum from femoral
blood was determined by immunoprecipitation with reagents
supplied by Roche (Roche Diagnostics, Switzerland). Catalytic
concentration of gamma glutamyl transferase (GGT) in post-
mortem serum from femoral blood was determined by standard
enzymatic procedures (Roche Diagnostics, Switzerland,
International Federation of Clinical Chemistry and Laboratory
Medicine (IFCC) reference measurement procedure at 37°C).
Determination of free urinary cortisol was performed by
RIA method.
Determination of free triiodothyronine (fT3) in postmortem
serum from femoral blood was performed by chemilumines-
cent microparticle immunoassay (Abbott Architect analyser,
Abbott reagents).
LBP was determined in postmortem serum from femoral
blood by chemiluminescent immunometric assay Immulite®2000
(Siemens Medical, Germany).
IL-6 was measured in postmortem serum from femoral
blood by the enzyme-linked immunosorbent assay (ELISA)
technique using a commercially available kit (R&D System,
Inc., Minneapolis, MN, USA).
IL-10 was measured in postmortem serum from femoral blood
by the ELISA technique using a commercially available kit.
Ethical issues
All relevant ethical issues were identified and discussed with
the local Ethical Committee. All cases collected for this study
underwent medico-legal autopsies as requested by the public
prosecutor. Biochemical analyses were performed as part of
the medico-legal investigations. All biological samples
were anonymized prior to analysis. No further ethical approval
was necessary to perform biochemical investigations in the
selected cases.
RESULTS
Detailed results for each analyzed marker and reference values,
if applicable, are reported in Table 2. Blood ethanol was un-
detectable in all subjects, whereas postmortem serum CDT
levels were increased in all individuals studied. All cases had
blood beta-hydroxybutyrate concentrations over 2500 µmol/l
and vitreous beta-hydroxybutyrate concentrations of at least
2400 µmol/l. Glycosuria was not detected in any of the cases
included in this study and glycated hemoglobin concentrations
were normal in all individuals examined. Vitreous glucose
levels were lower than <1 mmol/l and suggested the absence of
hyperglycemia at the time of death. Additionally, based on toxi-
cology results, none of these individuals had taken any agent
(other than ethanol) capable of causing hypoglycemia.
Vitreous lactate levels ranged from 26 to 32 mmol/l and
were not considered diagnostic evidence of antemortem lactic
acidosis, since values within this range are commonly found in
vitreous humor after death. However, it should be emphasized
that lactic acidosis can barely be diagnosed in the postmortem
setting in the absence of consistent antemortem clinical data.
Generalized, bacterial infections and sepsis, which are among
causes of lactic acidosis and may themselves be responsible for
death, were excluded in all cases based on autopsy and hist-
ology findings as well as normal PCT and LBP concentrations.
On the other hand, some degrees of gastrointestinal bleeding,
pancreatitis and liver disease, which can also be responsible for
antemortem increased lactate production, are common findings
in chronic alcoholics at postmortem examination and may in
part contribute to increased lactate levels.
CRP, IL-6 and IL-10 levels were increased in all individuals
studied. These results are not unexpected and appear to be un-
related to bacterial infections or sepsis, as confirmed by unre-
markable macroscopy, microscopy and bacteriology as well as
normal PCT and LBP concentrations. Moreover, similar find-
ings have recently been described in a series of fatal cases of
diabetic ketoacidosis in the absence of underlying bacterial
infections (Palmiere et al., 2013b).
Postmortem serum troponin I and NT-proBNP were at normal
levels. Pre-albumin concentrations were decreased in three cases,
not surprisingly, confirming that undernourishment can be con-
sidered one of the typical features of chronic alcohol abusers.
Conversely, albumin concentrations were not diminished and
even increased in one case, which might also be related to the
effect of hemoconcentration secondary to dehydration.
Postmortem serum insulin and C-peptide were appropriately
low in all subjects, as one would expect in individuals who are
starved and normoglycemic, while glucagon concentrations
were increased in four individuals. Postmortem serum cortisol
and urine free cortisol were elevated in all individuals studied,
along with decreased postmortem serum free triiodothyronine.
In living individuals, plasma triiodothyronine decreases soon
after the onset of fasting, but also during many serious illnesses.
Low triiodothyronine levels are therefore by no means a specif-
ic indicator of starvation. The decreased plasma triiodothyron-
ine in fasting and starvation (which may be an appropriate
adaptive response) in humans seems to result from decreased
hepatic thyroxine conversion, though decreased hepatic uptake
of thyroxine may also be a factor (Fulop, 1979; Fulop et al.,
1986). Cortisol levels in subjects with fast-induced ketosis have
been reported as unchanged or only mildly increased, in con-
trast to patients with either alcoholic or diabetic ketosis, whose
cortisol levels tend to be high-normal or elevated. Cortisol ele-
vations may promote lipolysis and ketogenesis, but this finding
cannot be considered specific since hypercortisolemia is
common in many acutely ill patients. In chronic alcoholics,
increased blood cortisol levels may be due to anxiety, aggres-
siveness and agitation that can be observed during the alcohol
withdrawal (Fulop, 1979). In the postmortem setting, elevated
cortisol levels in both postmortem serum and urine have been
formerly described in hypothermia fatalities (Ban´ka et al.,
2013; Palmiere et al., 2013c).
Pancreatic amylase activity and gamma glutamyl transferase
were elevated in all subjects. These results may suggest the
existence of underlying pancreatic and liver diseases, such as
alcoholic hepatitis of fatty liver, not completely unexpected in
chronic alcoholics. However, as observed by Michiue et al.,
increased pancreatic amylase and gamma glutamyl transferase
in postmortem samples may also indicate leakages from
respective tissues damaged by circulatory failure and hypoxia
in the death process (Michiue et al., 2013).
All subjects studied had increased postmortem serum free
fatty acids. In the clinical setting, increased blood free fatty acid
levels have been observed in patients with diabetic ketoacidosis
and starvation ketosis, albeit possibly not as much as in patients
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Table 2. The results for each analyzed marker and reference values in alcoholic ketoacidosis cases
Specimen and analyte Case 1 Case 2 Case 3 Case 4 Case 5 Case 6 Case 7 Case 8
Blood ethanol n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d.
Serum CDT 1.6% 2.2% 3.8% 3.6% 2.9% 3.0% 3.2% 3.3% 3.4%
Blood BHB
50–170 µmol/l
(0.52–1.77 mg/dl)
2600 µmol/l
(27.07 mg/dl)
3300 µmol/l
(34.36 mg/dl)
4200 µmol/l
(43.73 mg/dl)
2900 µmol/l
(30.19 mg/dl)
5000 µmol/l
(52.06 mg/dl)
5100 µmol/l
(53.10 mg/dl)
3000 µmol/l
(31.23 mg/dl)
4400 µmol/l
(45.81 mg/dl)
Glycated hemoglobin
5–6.6%
(31–49 mmol/mol)
5.8%
(40 mmol/mol)
5.4%
(36 mmol/mol)
6.0%
(42 mmol/mol)
5.8%
(40 mmol/mol)
5.2%
(33 mmol/mol)
5.2%
(33 mmol/mol)
5.6%
(38 mmol/mol)
5.2%
(33 mmol/mol)
Serum cortisol
170–630 nmol/l
(µg/dl) (8:00)
40–260 nmol/l
(µg/dl) (17:00)
1620 nmol/l
(58.71 µg/dl)
1260 nmol/l
(45.67 µg/dl)
2300 nmol/l
(83.36 µg/dl)
1100 nmol/l
(39.90 µg/dl)
960 nmol/l
(34.80 µg/dl)
2600 nmol/l
(94.24 µg/dl)
1440 nmol/l
(52.19 µg/dl)
1820 nmol/l
(66.00 µg/dl)
Serum free fatty acids
0.1–0.6 mmol/l
1.2 mmol/l 1.4 mmol/l 1.2 mmol/l 1.6 mmol/l 2.0 mmol/l 1.8 mmol/l 1.6 mmol/l 1.6 mmol/l
Serum PCT
<0.06 µg/l
<0.06 µg/l <0.06 µg/l <0.06 µg/l <0.06 µg/l <0.06 µg/l <0.06 µg/l <0.06 µg/l <0.06 µg/l
Serum CRP
<10 mg/l
39 mg/l 45 mg/l 51 mg/l 26 mg/l 36 mg/l 81 mg/l 40 mg/l 48 mg/l
Serum LBP
<10 µg/ml
6 µg/ml 8 µg/ml 5 µg/ml 6 µg/ml 4 µg/ml 7 µg/ml 6 µg/ml 8 µg/ml
Serum IL-6
<10 pg/ml
36 pg/ml 49 pg/ml 51 pg/ml 39 pg/ml 45 pg/ml 48 pg/ml 19 pg/ml 28 pg/ml
Serum IL-10
<10 pg/ml
28 pg/ml 54 pg/ml 24 pg/ml 44 pg/ml 49 pg/ml 55 pg/ml 18 pg/ml 37 pg/ml
Serum P-amylase
13–53 U/l
587 U/l 314 U/l 490 U/l 308 U/l 449 U/l 390 U/l 250 U/l 670 U/l
Serum gamma-GT
10–71 U/l
121 U/l 137 U/l 99 U/l 106 U/l 115 U/l 129 U/l 102 U/l 111 U/l
Serum insulin
5.0–18.0 µIU/ml
(34.7–125.0 pmol/l)
5.6 µIU/ml
(38.9 pmol/l)
6.2 µIU/ml
(43.1 pmol/l)
10.2 µIU/ml
(70.8 pmol/l)
6.6 µIU/ml
(45.8 pmol/l)
8.4 µIU/ml
(58.3 pmol/l)
9.1 µIU/ml
(63.2 pmol/l)
8.8 µIU/ml
(61.1 pmol/l)
6.4 µIU/ml
(44.4 pmol/l)
Serum C-peptide
0.7–3.0 µg/l or ng/ml
(0.23–1.0 nmol/l)
0.9 µg/l
(0.30 nmol/l)
1.1 µg/l
(0.37 nmol/l)
1.9 µg/l
(0.63 nmol/l)
1.0 µg/l
(0.33 nmol/l)
1.2 µg/l
(0.40 nmol/l)
1.6 µg/l
(0.53 nmol/l)
1.3 µg/l
(0.43 nmol/l)
0.9 µg/l
(0.30 nmol/l)
Serum glucagon
59–177 pg/ml or ng/l
182 pg/ml 107 pg/ml 201 pg/ml 156 pg/ml 199 pg/ml 170 pg/ml 255 pg/ml 114 pg/ml
Serum fT3
2.7–5.8 pmol/l
(175–377 pg/dl)
2.4 pmol/l
(156 pg/dl)
2.6 pmol/l
(169 pg/dl)
1.8 pmol/l
(117 pg/dl)
1.4 pmol/l
(91 pg/dl)
1.2 pmol/l
(78 pg/dl)
1.6 pmol/l
(104 pg/dl)
2.0 pmol/l
(130 pg/dl)
2.2 pmol/l
(143 pg/dl)
Serum urea nitrogen
2.9–7.7 mmol/l
(8.1–21.6 mg/dl)
8.2 mmol/l
(23.0 mg/dl)
6.8 mmol/l
(19.0 mg/dl)
12.1 mmol/l
(33.9 mg/dl)
7.2 mmol/l
(20.2 mg/dl)
6.4 mmol/l
(17.9 mg/dl)
13.4 mmol/l
(37.5 mg/dl)
6.6 mmol/l
(18.5 mg/dl)
7.6 mmol/l
(21.3 mg/dl)
Serum creatinine
62–106 µmol/l
(0.70–1.20 mg/dl)
112 µmol/l
(1.27 mg/dl)
99 µmol/l
(1.12 mg/dl)
135 µmol/l
(1.53 mg/dl)
88 µmol/l
(1.00 mg/dl)
79 µmol/l
(0.89 mg/dl)
141 µmol/l
(1.60 mg/dl)
80 µmol/l
(0.90 mg/dl)
104 µmol/l
(1.18 mg/dl)
Serum uric acid
202–416 µmol/l
(3.40–7.00 mg/dl)
528 µmol/l
(8.88 mg/dl)
630 µmol/l
(10.60 mg/dl)
668 µmol/l
(11.23 mg/dl)
702 µmol/l
(11.80 mg/dl)
590 µmol/l
(9.92 mg/dl)
621 µmol/l
(10.44 mg/dl)
780 µmol/l
(13.11 mg/dl)
715 µmol/l
(12.02 mg/dl)
Serum cTnI
<0.03 µg/l or ng/ml
0.07 µg/l 0.09 µg/l 0.06 µg/l 0.06 µg/l 0.10 µg/l 0.12 µg/l 0.08 µg/l 0.08 µg/l
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Table 2. Continued
Specimen and analyte Case 1 Case 2 Case 3 Case 4 Case 5 Case 6 Case 7 Case 8
Serum NT-proBNP
<115 ng/l
125 ng/l 130 ng/l 148 ng/l 120 ng/l 98 ng/l 110 ng/l 90 ng/l 110 ng/l
Serum pre-albumin
18–45 mg/dl
15 mg/dl 31 mg/dl 16 mg/dl 38 mg/dl 15 mg/dl 30 mg/dl 39 mg/dl 26 mg/dl
Serum albumin
35–52 g/l
44 g/l 48 g/l 36 g/l 61 g/l 42 g/l 44 g/l 36 g/l 38 g/l
Urine free cortisol
100–400 nmol/l
(3.62–14.50 µg/dl)
940 nmol/l
(34.07 µg/dl)
720 nmol/l
(26.10 µg/dl)
1140 nmol/l
(41.32 µg/dl)
1000 nmol/l
(36.25 µg/dl)
680 nmol/l
(24.65 µg/dl)
2080 nmol/l
(75.39 µg/dl)
880 nmol/l
(31.90 µg/dl)
1260 nmol/l
(45.67 µg/dl)
Urine glucose
<0.8 mmol/l
(<14 mg/dl)
<0.8 mmol/l
(<14 mg/dl)
<0.8 mmol/l
(<14 mg/dl)
<0.8 mmol/l
(<14 mg/dl)
<0.8 mmol/l
(<14 mg/dl)
<0.8 mmol/l
(<14 mg/dl)
<0.8 mmol/l
(<14 mg/dl)
<0.8 mmol/l
(<14 mg/dl)
<0.8 mmol/l
(<14 mg/dl)
Vitreous sodium
135–145 mmol/l or mEq/l
136 mmol/l 138 mmol/l 134 mmol/l 136 mmol/l 135 mmol/l 130 mmol/l 134 mmol/l 139 mmol/l
Vitreous chloride
98–110 mmol/l or mEq/l
90 mmol/l 88 mmol/l 86 mmol/l 84 mmol/l 92 mmol/l 78 mmol/l 80 mmol/l 92 mmol/l
Vitreous glucose <1 mmol/l <1 mmol/l <1 mmol/l <1 mmol/l <1 mmol/l <1 mmol/l <1 mmol/l <1 mmol/l
Vitreous lactate 28 mmol/l 30 mmol/l 32 mmol/l 28 mmol/l 26 mmol/l 32 mmol/l 24 mmol/l 26 mmol/l
Vitreous BHB
50–170 µmol/l
(0.52–1.77 mg/dl)
2400 µmol/l
(25.00 mg/dl)
3000 µmol/l
(31.23 mg/dl)
3900 µmol/l
(40.60 mg/dl)
2700 µmol/l
(28.11 mg/dl)
4800 µmol/l
(49.97 mg/dl)
4800 µmol/l
(49.97 mg/dl)
2600 µmol/l
(27.07 mg/dl)
4000 µmol/l
(41.64 mg/dl)
Blood ethanol: n.d.: not detected. Limit of decision: 0.1 g/kg.
Serum: postmortem serum from femoral blood.
BHB, beta-hydroxybutyrate. Other abbreviations are reported in the text.
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with alcoholic ketoacidosis (Fulop, 1979). In a study focusing
on the biochemical markers of hypothermia fatalities, increased
postmortem serum free fatty acid concentrations were observed
not only in subjects who died from hypothermia but also in
control individuals, possibly indicating the postmortem leakage
of these molecules in the bloodstream following cellular autoly-
sis and decompositional change onset, irrespective of the cause
of death (Palmiere et al., 2013c).
Most postmortem serum creatinine and urea nitrogen levels
were normal in the subjects studied, although intravascular
volume depletion and mild renal insufficiency may be seen in
subjects with alcoholic ketoacidosis. These findings concur
with those of former reports, which highlighted that blood
urea nitrogen may be low, normal or elevated depending on
the degree of starvation, intravascular volume depletion, mal-
nutrition, presence of blood in the gastrointestinal tract and
chronic liver disease (Duffens and Marx, 1987).
Vitreous sodium concentrations were normal or only slight-
ly decreased, likely reflecting total body sodium depletion,
whereas hypochloremia was systematically observed, possibly
secondary to prolonged vomiting.
Lastly, all individuals studied were hyperuricemic, a condi-
tion that has also been found in patients with diabetic and
starvation-induced ketosis (Fulop and Hoberman, 1975).
Hyperuricemia is not surprising in cases of alcoholic ketoaci-
dosis since decreased renal perfusion due to dehydration,
increased tissue catabolism and competitive inhibition of renal
excretion of uric acid by beta-hydroxybutyrate and acetoace-
tate (and lactate, when present) are all prevalent in such situ-
ation (Soffer and Hamburger, 1982; Caspar et al., 1993).
DISCUSSION
To date, no extensive studies have been performed in the fo-
rensic field focusing on the metabolic and endocrine disorders
that characterize the syndrome of alcoholic ketoacidosis and
can be detected by postmortem biochemical investigations.
Exceptions are the reports pertaining to acetone and beta-
hydroxybutyrate determination and, more recently, CRP meas-
urement. This lack of literature may seem surprising, especial-
ly considering that alcoholic ketoacidosis is commonly found
in ethanol abusers in emergency departments worldwide.
Furthermore, deaths related to chronic ethanol consumption
account for a significant part of the forensic work (Denmark,
1993;Höjer, 1996).
It is known that several situations may be encountered in fo-
rensic pathology routine with negative autopsy and histology
findings. Some of these otherwise unexplained cases concern
sudden deaths in chronic alcoholics (Pounder et al., 1998;
Teresin´ski et al., 2009). Although numerous observations have
been made in the clinical setting describing the correlation
among chronic alcohol abuse, repeated vomiting, alcohol with-
drawal, prolonged fasting, poor fluid intake, endocrine and bio-
chemical disorders, severe ketoacidosis and death, the
medico-legal literature on alcoholic ketoacidosis is relatively
scant and probably belies the true frequency of this condition.
The paucity of publications on this topic may be in part attribut-
able to the fact that biochemical analyses are not integrated in
routine autopsy investigations in most medico-legal centers or
are limited to the determination of specific compounds
(acetone) exclusively in blood.
When the diagnosis of alcoholic ketoacidosis is suspected
based on medical and social histories of the deceased, scene
investigation findings as well as negative autopsy, pathologists
should consider the following:
– Blood beta-hydroxybutyrate concentration seems to be a
more suitable indicator of ketoacidosis than blood
acetone and, therefore, should be the preferred biochem-
ical marker in the postmortem setting.
– Beta-hydroxybutyrate concentrations over 25 mg/dl
(2400 µmol/l) in the blood can be considered pathologic-
ally significant according to reviewed reports. The cause
of death can be attributed to alcoholic ketoacidosis when
medical records, social history and scene investigation
findings are consistent with this hypothesis and post-
mortem investigation results allow alternative causes of
death to be reasonably excluded.
– Low levels of acetone in blood do not preclude the pres-
ence of pathologically significant beta-hydroxybutyrate
concentrations. Hence, acetone and beta-hydroxybutyrate
should both be systematically measured in order to have a
more complete metabolic overview of the case.
– Isopropyl alcohol should be systematically determined
since some excess acetone undergoes endogenous reduc-
tion to isopropyl alcohol via the reversible action of alcohol
dehydrogenase. Isopropyl alcohol can be detected in
several situations of forensic interest, beyond direct expos-
ure to isopropyl alcohol itself, which are characterized by
increased acetone levels and an elevated NADH/NAD+
ratio, such as diabetic and alcoholic ketoacidosis as well as
hypothermia fatalities and starvation. It must be empha-
sized, however, that low or undetectable levels of isopropyl
alcohol in blood do not preclude the diagnosis of alcoholic
ketoacidosis.
– Blood ethanol should be systematically determined.
Ethanol can be undetectable or present at low concentra-
tions in alcoholic ketoacidosis.
– Vitreous humor and pericardial fluid can be considered
reliable alternatives to blood for acetone and beta-
hydroxybutyrate (and isopropyl alcohol) determination
should blood be unavailable during autopsy or reserved
for toxicological purposes.
– Alcoholic ketoacidosis is generally characterized by
normal glucose levels in both vitreous and urine, with the
exception of diabetic individuals who abuse ethanol.
– Vitreous glucose and glycated hemoglobin should be sys-
tematically measured. Diabetic ketoacidosis should
always be considered in the differential diagnosis since
clinical presentations of diabetic and alcoholic ketoacido-
sis may be similar. Significant increases in vitreous and
urine glucose concentrations may reflect the existence of
uncontrolled diabetes mellitus and must be evaluated in
the context of a more general metabolic dysfunction,
along with glycated hemoglobin, beta-hydroxybutyrate,
acetoacetate, acetone and isopropyl alcohol concentra-
tions.
– Increased lactate levels in vitreous humor require careful
interpretations. Vitreous lactate concentrations within the
range of 26–30 mmol/l (230–270 mg/dl) may be a
common finding after death. It has been shown that vitre-
ous lactate levels rise with increasing postmortem time and
that the postmortem vitreous lactate concentrations are due
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not only to the antemortem vitreous lactate levels and the
postmortem metabolism of glucose, but other sources can
also be responsible for lactate formation in vitreous and
subsequent increased vitreous lactate concentrations after
death. Pancreatic and liver disease is frequently observed in
chronic alcoholics at autopsy and can be responsible for
increased lactate levels. Generalized, bacterial infections
and sepsis can also contribute to increased lactate levels
and be responsible for death themselves.
– Bacterial infections and sepsis as the sole or main con-
tributing cause of death should be systematically sought
out through microbiology and biochemical marker deter-
mination, including at least PCT.
– Elevated CRP, IL-6 and IL-10 concentrations may be
observed in the absence of underlying bacterial infections.
– CDT should be systematically measured to support and
corroborate the hypothesis of chronic alcohol abuse.
– Adaptive endocrine reactions in alcoholic ketoacidosis
with prolonged fasting may include normal or low
insulin and decreased free triiodothyronine as well as
increased glucagon and cortisol. Hormonal responses
that can be diagnosed in living individuals should also be
sought out in appropriate postmortem samples.
– Sodium and chloride in vitreous as well as urea nitrogen,
creatinine and uric acid in postmortem serum should be
systematically measured in order to estimate the severity
of volume depletion.
– Pre-albumin and albumin should be systematically deter-
mined to estimate the severity of undernourishment.
However, relative increases in albumin concentrations may
be related to hemoconcentration and dehydration.
– The determination of other biochemical markers such as
free fatty acids, pancreatic amylase and gamma glutamyl
transferase in postmortem serum is by no means diagnos-
tic. Increases in pancreatic amylase and gamma glutamyl
transferase may be the consequence of terminal heart
failure and cannot be related to alcoholic ketoacidosis in
itself.
– Increased concentrations of certain molecules might be
an expression of preexisting diseases or follow the onset
of decompositional changes. Isolated findings should
therefore never be overestimated and always require
careful interpretation in the context of all biochemical
results, postmortem investigation findings and exclusion
of other causes of death.
– Elevated blood beta-hydroxybutyrate, acetone and iso-
propyl alcohol, along with increased blood and urine cor-
tisol as well as normal vitreous and urine glucose levels,
may also be found in hypothermia fatalities. Considering
that chronic alcoholics are not only at risk of alcoholic
ketoacidosis but also fatal hypothermia, biochemical data
must always be integrated and interpreted in the context
of global findings.
To conclude, alcoholic ketoacidosis is a recognized acute
complication in ethanol-dependent subjects and should always
be considered as a possible cause of death when examining
chronic alcohol abusers who suddenly died unwitnessed. In
the clinical field, the syndrome is associated with a variety of
laboratory abnormalities. Some of these can also be reliably
investigated and diagnosed in the postmortem setting, pro-
vided that biochemical analyzes are integrated in routine
autopsy investigations, particularly ethanol, ketones and CDT
as well as markers of volume depletion and undernourishment.
The correlation of medical history and scene investigation
findings as well as autopsy, histology, microbiology, toxicol-
ogy and biochemical results thus prove decisive in formulating
appropriate hypothesis concerning the cause of death as well
as identifying precipitating conditions and predisposing disor-
ders. Exhaustive postmortem investigations can thereby allow
the exclusion of alternative causes of death (namely diabetic
ketoacidosis, hypothermia and ethanol intoxication) to be
established and the conclusion of alcoholic ketoacidosis as the
cause of death to be reasonably reached.
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